Venus Concept
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Venus Concept sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Venus Concept: 22 sponsored US clinical trials, 2 recruiting.
Venus Concept sponsors 22 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 14 completed. The most-studied condition in this pipeline is Wrinkle, with 2 trials.
Top-decile sponsor footprint
Venus Concept ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
22 total, page 1 of 1
Fractional Radiofrequency for Reduction of Surgical Scar Formation
NCT05897723
Computer-Assisted Hair Restoration Study Using ARTAS System
NCT05938569
Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.
NCT05256771
Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
NCT04827680
Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty
NCT04616898
Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction
NCT04012814
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
NCT04057768
Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
NCT03776461
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
NCT03831477
Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring
NCT03821324
Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)
NCT03756350
Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser (Flanks)
NCT03756168
Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring
NCT03767153
RF/PEMF Versus Ultrasound for the Treatment of Soft Tissue Injury
NCT03774823
LED Device for Non-Invasive Lipolysis
NCT03171051
Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris
NCT02924428
Tolerability of Using a Post-Treatment Topical Adjuvant Combination Following Fractional Radiofrequency Ablation
NCT02896569
Radiofrequency and Pulsed Electromagnetic Field Treatment of Skin Laxity of the Mon Pubis, Labia and Vaginal Introitus
NCT02770287
Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction & Laxity of the Flanks
NCT02569112
Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference
NCT02492997
Clinical Evaluation of Using Intense Pulsed Light for Improving the Appearance of Striae Distensae
NCT02452359
Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types VI Using Intense Pulsed Light
NCT02452398
Therapeutic Areas
What is open in the Venus Concept pipeline
2 recruiting of 22 indexed (9% open); 14 completed (64%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Wrinkle (2 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Venus Concept: open-pipeline peers nationwide
Peers matched on 22 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Venus Concept sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 trials (± recruiting share)
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this Venus Concept page
22 registered trials is a research-attention snapshot, not an endorsement of Venus Concept or any single study.
- 2 of Venus Concept's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Wrinkle is the condition Venus Concept studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Wrinkle trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Venus Concept pipeline card: 22 registered trials from official public datasets.Report a data error.